What Geneva Biotech Center does

Geneva Biotech Center is described as a for-profit Swiss private company, founded in 2013 and headquartered in Geneva, Switzerland, that positions itself around the outsourcing trend among pharmaceutical companies for research and development capabilities. The firmographic record indicates 11-50 employees, though no products, services, customer segments, leadership team, technology stack, pricing, or partnership data is available in the input — the bulk of the source material originates from a domain marketplace listing (GoDaddy / ExpiredDomains.com) showing the company's primary domain, genevabiotechcenter.com, has expired and is offered for resale at $395 USD. The corporate record reflects only one disclosed funding event: a 2014 round with Eclosion SA listed as sole investor and lead, with a disclosed amount of $0 (consistent with an undisclosed convertible or nominal-value instrument).

There is no evidence in the input of an active operating business: the domain was registered 29/08/2012, first crawled by the Wayback Machine in 2013, and has since lapsed. Operating status, revenue, ownership, headcount, and management cannot be independently verified from any first-party source. On the balance of evidence, Geneva Biotech Center appears to be either dormant, dissolved, or operating entirely off the public web under the same or a successor name. Any diligence hypothesis should treat the firmographic attributes (11-50 employees, founded 2013) as unverified baseline claims rather than current facts.

Name

Geneva Biotech Center

Website

https://genevabiotechcenter.com

Company type

Private

Founded year

2013

Operating status

Unknown

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Contract Pharmaceutical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

akta.pro secondary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Pharmaceutical R&D outsourcing
• Drug discovery services
• Contract research services
• Biotech research outsourcing
• Preclinical development services

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Geneva Biotech Center provides outsourced research and development capabilities to pharmaceutical companies. The firm operates as a contract research organization supporting drug discovery and development workflows for pharma clients in Switzerland and internationally.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical R&D Outsourcing Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Direct peers

• Eurofins Scientific: Europe-based bioanalytical and contract laboratory services provider with strong pharma/biotech testing capabilities — comparable contract research service offering.
• Charles River Laboratories: Contract research organization offering preclinical and clinical lab services for biotech and pharma — directly comparable R&D outsourcing model.
• Syneos Health: Fully integrated CRO offering clinical development and commercial services to biopharma — comparable end-to-end outsourced R&D service model.
• Lonza Group: Swiss-headquartered global CDMO offering contract development and manufacturing for pharma and biotech — the most direct European peer for a Geneva-based biotech R&D services outfit.
• ICON plc: Global CRO providing outsourced clinical and laboratory services to pharma, biotech and medical device clients — a directly comparable R&D outsourcing peer.

Broad incumbents

• IQVIA: Largest global CRO providing clinical research and life sciences R&D outsourcing services, representative of the large incumbents in the same outsourcing category Geneva Biotech Center targets.
• WuXi AppTec: Global CRO/CDMO providing outsourced R&D and manufacturing services across the drug development lifecycle — directly comparable in service model.
• SGS Société Générale de Surveillance: Swiss-headquartered testing, inspection and certification company with a Life Sciences division providing contract laboratory services — comparable on the lab-services side of the R&D outsourcing market.

Emerging players

• Pharmaron: China-anchored but globally expanding CRO/CDMO offering drug discovery, preclinical and CMC services — comparable outsourced R&D service model with a growth-oriented profile.

Regional players

• Debiopharm: Swiss-headquartered biopharma group with contract development capabilities serving global pharma partners — a regional peer operating from the same Swiss ecosystem.

Market position

Strengths2 records

Weaknesses3 records

Key risks4 records

Key highlights2 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geneva Biotech Center